Shalini Gupta

Shalini Gupta is a seasoned expert in translational safety and bioanalytical sciences with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director at Amgen since July 2023, Shalini Gupta leads immunogenicity monitoring strategies for large molecule modalities and oversees collaborations with contract research organizations (CROs). Prior to this role, Shalini Gupta held multiple director positions at Amgen, emphasizing advancements in immunogenicity methods and bioanalysis. Additionally, Shalini Gupta has contributed to the American Association of Pharmaceutical Scientists (AAPS) as Bioanalytical Community Chair and has participated in the US Pharmacopeia's Immunology Methods Expert Group. Educational qualifications include postdoctoral studies in biochemistry from both Cornell University and UCLA, coupled with foundational experience at Athena Neurosciences.